EWTX FY 2024 Earnings — Edgewise Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

EWTXEdgewise Therapeutics, Inc.

$3B

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$159M

Net Income

-$134M

EPS (Diluted)

$-1.45

Cash Flow

Operating Cash Flow

-$109M

Free Cash Flow

-$110M

Stock-Based Comp.

$25M

Balance Sheet

Total Assets

$487M

Total Liabilities

$28M

Stockholders' Equity

$459M

Cash & Equivalents

$42M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$159M	-$114M	-38.9%
Net Income	-$134M	-$100M	-33.6%